Results 41 to 50 of about 4,080,754 (294)

Indomethacin-based PROTACs as pan-coronavirus antiviral agents

open access: yesEuropean journal of medicinal chemistry, 2021
Indomethacin (INM), a well-known non-steroidal anti-inflammatory drug, has recently gained attention for its antiviral activity demonstrated in drug repurposing studies against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
J. Desantis   +9 more
semanticscholar   +1 more source

Plant-derived lignans as potential antiviral agents: a systematic review

open access: yesPhytochemistry Reviews, 2021
Medicinal plants are one of the most important sources of antiviral agents and lead compounds. Lignans are a large class of natural compounds comprising two phenyl propane units. Many of them have demonstrated biological activities, and some of them have
Xin-Ya Xu   +4 more
semanticscholar   +1 more source

Development of nanoparticle-delivery systems for antiviral agents: A review

open access: yesJournal of Controlled Release, 2021
The COVID-19 pandemic has resulted in unprecedented increases in sickness, death, economic disruption, and social disturbances globally. However, the virus (SARS-CoV-2) that caused this pandemic is only one of many viruses threatening public health ...
Rana Delshadi   +4 more
semanticscholar   +1 more source

Antiviral Agents

open access: yes, 2009
Antiviral agents are drugs approved in the USA by the Food and Drug Administration (FDA) for the treatment or control of viral infections. Available antiviral agents mainly target stages in the viral life cycle. The target stages in the viral life cycle are; viral attachment to host cell, uncoating, synthesis of viral mRNA, translation of mRNA ...
Paintsil, E., Cheng, Yung-Chi
openaire   +2 more sources

Carbon-Based Nanomaterials: Promising Antiviral Agents to Combat COVID-19 in the Microbial-Resistant Era

open access: yesACS Nano, 2021
Therapeutic options for the highly pathogenic human severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing the current pandemic coronavirus disease (COVID-19) are urgently needed.
Ã. Serrano-Aroca   +22 more
semanticscholar   +1 more source

Can biopolymers act as antiviral agents?

open access: yeseXPRESS Polymer Letters, 2020
editorial
J. Seppala, S. Borandeh
doaj   +1 more source

Essential Oils as Antiviral Agents, Potential of Essential Oils to Treat SARS-CoV-2 Infection: An In-Silico Investigation

open access: yesInternational Journal of Molecular Sciences, 2020
Essential oils have shown promise as antiviral agents against several pathogenic viruses. In this work we hypothesized that essential oil components may interact with key protein targets of the 2019 severe acute respiratory syndrome coronavirus 2 (SARS ...
J. D. da Silva   +3 more
semanticscholar   +1 more source

Complexes of Ruthenium(II) as Promising Dual-Active Agents against Cancer and Viral Infections

open access: yesPharmaceuticals, 2023
Poor responses to medical care and the failure of pharmacological treatment for many high-frequency diseases, such as cancer and viral infections, have been widely documented.
Assunta D’Amato   +6 more
doaj   +1 more source

Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma [PDF]

open access: yesClinical and Molecular Hepatology, 2021
Over the past several decades, entecavir (ETV) and tenofovir disoproxil fumarate (TDF) have remained the first-line antiviral agents in several international guidelines.
Sung Won Lee   +3 more
doaj   +1 more source

Broad‐Spectrum Antiviral Agents Based on Multivalent Inhibitors of Viral Infectivity

open access: yesAdvanced Healthcare Materials, 2021
The ongoing pandemic of the coronavirus disease (Covid‐19), caused by the spread of the severe acute respiratory syndrome coronavirus 2 (SARS CoV‐2), highlights the need for broad‐spectrum antiviral drugs.
A. Zelikin, F. Stellacci
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy